These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 22727437
1. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction. Çanga A, Durakoğlugil ME, Erdoğan T, Kirbaş A, Yilmaz A, Çiçek Y, Ergül E, Çetin M, Kocaman SA. J Cardiol; 2012 Nov; 60(5):355-60. PubMed ID: 22727437 [Abstract] [Full Text] [Related]
2. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging. Fuernau G, Zaehringer S, Eitel I, de Waha S, Droppa M, Desch S, Schuler G, Adams V, Thiele H. Int J Cardiol; 2013 Sep 01; 167(5):2134-9. PubMed ID: 22704876 [Abstract] [Full Text] [Related]
3. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, Ergin A, Gibson CM. Am J Cardiol; 2012 Sep 01; 110(5):621-7. PubMed ID: 22608360 [Abstract] [Full Text] [Related]
4. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Shen J, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF. Coron Artery Dis; 2008 Jun 01; 19(4):271-7. PubMed ID: 18480672 [Abstract] [Full Text] [Related]
5. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Pedersen S, Mogelvang R, Bjerre M, Frystyk J, Flyvbjerg A, Galatius S, Sørensen TB, Iversen A, Hvelplund A, Jensen JS. Cardiology; 2012 Jun 01; 123(1):31-8. PubMed ID: 22964478 [Abstract] [Full Text] [Related]
7. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Zhao L, Wang L, Zhang Y. J Invasive Cardiol; 2009 Oct 01; 21(10):493-8. PubMed ID: 19805833 [Abstract] [Full Text] [Related]
8. High osteoprotegerin levels predict MACCE in STEMI patients, but are not associated with myocardial salvage. Bjerre M, Munk K, Sloth AD, Nielsen SS, Flyvbjerg A, Bøtker HE. Scand Cardiovasc J; 2014 Aug 01; 48(4):209-15. PubMed ID: 24758546 [Abstract] [Full Text] [Related]
10. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging. Eitel I, Nowak M, Stehl C, Adams V, Fuernau G, Hildebrand L, Desch S, Schuler G, Thiele H. Am Heart J; 2010 May 01; 159(5):882-90. PubMed ID: 20435200 [Abstract] [Full Text] [Related]
12. Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Postma S, Heestermans T, Ten Berg JW, van Werkum JW, Suryapranata H, Birnbaum Y, Hamm CW, van 't Hof AW. J Electrocardiol; 2011 May 01; 44(5):516-22. PubMed ID: 21871998 [Abstract] [Full Text] [Related]
13. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention]. Wang JW, Chen YD, Wang CH, Zhu XL. Zhonghua Yi Xue Za Zhi; 2012 Nov 27; 92(44):3100-3. PubMed ID: 23328417 [Abstract] [Full Text] [Related]
14. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction]. Cağli KE, Topaloğlu S, Aras D, Günel EN, Ozlü MF, Uygur B, Baysal E, Sen N. Turk Kardiyol Dern Ars; 2009 Jan 27; 37(1):19-25. PubMed ID: 19225249 [Abstract] [Full Text] [Related]
15. Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Damman P, Kuijt WJ, Woudstra P, Haeck JD, Koch KT, Gu YL, van Straalen JP, Fischer J, Tijssen JG, Krucoff MW, de Winter RJ. Am Heart J; 2012 May 27; 163(5):783-9. PubMed ID: 22607855 [Abstract] [Full Text] [Related]
17. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Stankovic S, Asanin M, Trifunovic D, Majkic-Singh N, Miljković A, Ignjatovic S, Mrdovic I, Matic D, Savic L, Ostojic M, Vasiljevic Z. Clin Lab; 2012 May 27; 58(11-12):1135-44. PubMed ID: 23289182 [Abstract] [Full Text] [Related]
18. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Sen N, Afsar B, Ozcan F, Buyukkaya E, Isleyen A, Akcay AB, Yuzgecer H, Kurt M, Karakas MF, Basar N, Hajro E, Kanbay M. Atherosclerosis; 2013 May 27; 228(1):203-10. PubMed ID: 23489347 [Abstract] [Full Text] [Related]
19. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction. Celik T, Iyisoy A, Yuksel CU, Kilic S, Yilmaz MI, Akgul EO, Jata B, Isik E. Coron Artery Dis; 2008 Dec 27; 19(8):543-9. PubMed ID: 19005288 [Abstract] [Full Text] [Related]
20. Suboptimal coronary blood flow after primary percutaneous coronary intervention for acute myocardial infarction: incidence, a simple risk score, and prognosis. Uyarel H, Ayhan E, Cicek G, Isik T, Ugur M, Bozbay M, Yildirim E, Ergelen M, Eren M. Coron Artery Dis; 2012 Mar 27; 23(2):98-104. PubMed ID: 22318130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]